Hormones and Genes of Importance in Bone Physiology and Their Influence on Bone Mineralization and Growth in Turner Syndrome

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Hormone Research in Paediatrics

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000284356PMID 20197667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain

  2009cited by this paper
• Fracture risk and bone mineral density in Turner syndrome

  2008cited by this paper
• Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group.

  2007cited by this paper
• Gone with the Wnts: β-Catenin, T-Cell Factor, Forkhead Box O, and Oxidative Stress in Age-Dependent Diseases of Bone, Lipid, and Glucose Metabolism

  2007cited by this paper
• BNP is a transcriptional target of the short stature homeobox gene SHOX.

  2007cited by this paper
• Childhood Bone Mass Acquisition and Peak Bone Mass May Not Be Important Determinants of Bone Mass in Late Adulthood

  2007cited by this paper
• Oxidative Stress Antagonizes Wnt Signaling in Osteoblast Precursors by Diverting β-Catenin from T Cell Factor- to Forkhead Box O-mediated Transcription*

  2007cited by this paper
• Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism.

  2007cited by this paper
• A mouse model for human short-stature syndromes identifies Shox2 as an upstream regulator of Runx2 during long-bone development.

  2006cited by this paper
• Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.

  2006cited by this paper
• Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency

  2006cited by this paper
• Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

  2005cited by this paper
• Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry.

  2004cited by this paper
• Expression of SHOX in human fetal and childhood growth plate.

  2004cited by this paper
• The Short Stature Homeodomain Protein SHOX Induces Cellular Growth Arrest and Apoptosis and Is Expressed in Human Growth Plate Chondrocytes*

  2004cited by this paper
• Fundamental limits on longitudinal bone growth: growth plate senescence and epiphyseal fusion.

  2004cited by this paper
• The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice.

  2004cited by this paper
• Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey

  2003cited by this paper
• Selective reduction in cortical bone mineral density in turner syndrome independent of ovarian hormone deficiency.

  2003cited by this paper
• Favorable Final Height Outcome in Girls with Ullrich-Turner Syndrome Treated with Low-Dose Growth Hormone Together with Oxandrolone Despite Starting Treatment After 10 Years of Age

  2002cited by this paper
• Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors

  2002cited by this paper
• The role of the resting zone in growth plate chondrogenesis.

  2002cited by this paper
• Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography.

  2001cited by this paper
• SHOX haploinsufficiency and overdosage: impact of gonadal function status

  2001cited by this paper
• Expression of cyclin-dependent kinase inhibitors in epiphyseal chondrocytes induced to terminally differentiate with thyroid hormone.

  2000cited by this paper
• Four decades of growth hormone therapy for short children: what have we achieved?

  1999cited by this paper
• Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.

  1999cited by this paper
• Growth Hormone Therapy in Patients with Turner Syndrome

  1998cited by this paper
• Growth hormone therapy in patients with Turner syndrome.

  1998cited by this paper
• Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III

  1997cited by this paper
• Bone mineral density in Turner's syndrome—a longitudinal study

  1997cited by this paper
• Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.

  1996cited by this paper
• Age and bone mass as predictors of fracture in a prospective study.

  1988cited by this paper

• Prevention of Growth Failure in Turner Syndrome: Long-Term Results of Early Growth Hormone Treatment in the “Toddler Turner” Cohort

  2021cites this paper
• Monitoring and maintaining bone health in patients with Turner syndrome

  2020cites this paper
• Pattern and Etiology of Growth Disturbance in Turner Syndrome and Outcomes of Growth-Promoting Treatments

  2020cites this paper
• Dosage of estradiol, bone and body composition in Turner syndrome: a 5-year randomized controlled clinical trial.

  2017cites this paper
• Mass spectrometry imaging: a novel technology in rheumatology

  2017cites this paper
• MALDI mass spectrometry imaging in rheumatic diseases.

  2017cites this paper
• MicroRNA-27 a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP 1 through the Wnt / β-Catenin Signaling Pathway

  2017cites this paper
• Turner Syndrome: Care of the Patient: Birth to Late Adolescence.

  2017cites this paper
• MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway

  2017cites this paper
• Sex Steroid Replacement Therapy in Female Hypogonadism from Childhood to Young Adulthood.

  2016cites this paper
• The current management of Turner Syndrome.

  2016cites this paper
• Why Treat girls with Turner Syndrome with Growth Hormone? Growth and Beyond.

  2015cites this paper
• Turner Syndrome: Pathophysiology, Diagnosis and Treatment

  2014cites this paper
• Gonadal Hormones, Diseases, and Emerging Therapeutics

  2012cites this paper
• The role of the SHOX gene in the pathophysiology of Turner syndrome.

  2011cites this paper
• CARACTERIZACIÓN DE LAS ALTERACIONES EN LA FUNCION RENAL, LA PRESION ARTERIAL Y LAS MALFORMACIONES ANATÓMICAS RENALES- URINARIAS Y CARDIOVASCULARES EN PACIENTES CON SINDROME DE TURNER EN LA FUNDACION CARDIOINFANTIL ENTRE 1999 Y 2009

  2011cites this paper
• Endocrine diseases, perspectives and care in Turner syndrome.

  2011cites this paper
• Bone mineral density in pediatric inflammatory bowel disease

  2010cites this paper